As a regulatory inhibitor of cell cycle, the retinoblastoma protein (Rb) is central to a tumor suppressive pathway that is frequently disrupted in human cancer. LOH of the retinoblastoma gene (Rb) is one of the most common mutations associated with prostate cancer and through much of the molecular function of Rb is known, it's role in the pathobiology of prostate cancer has not been investigated. Some of the mutation events that occur during the prostate tumorigenesis involve alterations to apoptotic programs present in normal prostate epithelium. Therefore, the ability of prostate epithelial cells to circumvent apoptosis may be important in prostate tumorigenesis. During the first two years of our SPORE-funded research, we develop two cell culture models with which we have demonstrated that apoptosis of prostate epithelial cells is uniquely regulated through the Rb cell cycle control pathway. Additionally, we have shown that activation of the Rb pathway occurs in the rat prostate gland during castration-induced apoptosis. Based on these studies, we hypothesize that the loss of Rb function may facilitate tumor formation by inactivating an Rb-dependent apoptotic mechanism. To elucidate the role of Rb in prostate tumorigenesis we have developed a unique in vivo model system with which to study homozygous deletion of the RB gene in mouse prostate epithelium. We will also determine the efficacy of an Rb adenoviral construct to induce apoptosis of prostate cancer cells. We will pursue these goals by addressing the following specific aims.
Specific Aim 1. To investigate the tumorigenic effects of Rb deletion over time, we will analyze Rb-/-E in the TR system for tumor formation over a period of one year.
Specific Aim 2. To investigate the tumorigenic effect of Rb deletion in the TR system, we will analyze Rb-/- E in the presence of tumor stroma.
Specific Aim 3. To determine if constitutively active Rb, delivered with the adenovirus system will induce apoptosis of prostate cancer cells. We anticipate that the results from this study would be the first to identify a pathobiological role for Rb in prostate tumorigenesis and the first to define a critical component of an androgen-regulated apoptotic program in prostate epithelium in vivo.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA069568-05
Application #
6203364
Study Section
Project Start
1999-08-09
Project End
2003-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Xie, Yuanyuan; Cao, Zhen; Wong, Elissa Wp et al. (2018) COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors. J Clin Invest 128:1442-1457
Singhal, Udit; Wang, Yugang; Henderson, James et al. (2018) Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature. Mol Cancer Res 16:643-654
Rye, Morten Beck; Bertilsson, Helena; Andersen, Maria K et al. (2018) Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized. BMC Cancer 18:478
Wang, Xiaoju; Qiao, Yuanyuan; Asangani, Irfan A et al. (2017) Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer. Cancer Cell 31:532-548.e7
Blattner, Mirjam; Liu, Deli; Robinson, Brian D et al. (2017) SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. Cancer Cell 31:436-451
Dai, Xiangpeng; Gan, Wenjian; Li, Xiaoning et al. (2017) Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Nat Med 23:1063-1071
Lin, Ke-Chih; Torga, Gonzalo; Wu, Amy et al. (2017) Epithelial and mesenchymal prostate cancer cell population dynamics on a complex drug landscape. Converg Sci Phys Oncol 3:
Chen, Weiqiang; Allen, Steven G; Reka, Ajaya Kumar et al. (2016) Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics. BMC Cancer 16:614
Hu, Shuhuan; Liu, Guangyu; Chen, Weiqiang et al. (2016) Multiparametric Biomechanical and Biochemical Phenotypic Profiling of Single Cancer Cells Using an Elasticity Microcytometer. Small 12:2300-11
Piert, Morand; Montgomery, Jeffrey; Kunju, Lakshmi Priya et al. (2016) 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies. J Nucl Med 57:1065-70

Showing the most recent 10 out of 527 publications